To view on your mobile phone, please click here.

To view this email online, please click here.
 
To ensure delivery to your inbox, please add pharmtech@mail.pharmtech.com to your address book
Sourcing and Management by Pharmaceutical Technology
Visit PharmTech.com
About PTSM and Subscribe
Archives
Contact Editorial

September 2014 Volume 10 Issue 9

PRINT SUBSCRIBE
DIGITAL SUBSCRIBE


In this issue: News, interviews, and articles on advances in outsourcing relationships, biopharma business opportunities in Africa, meeting regulatory requirements for supply chain safety, and other business news.



Outsourcing
Contract Services Ride High As Funding Floods Bio/Pharma
By Jim Miller
Biopharma manufacturers must reduce the risk in their complex supply chains.
More ...

Contract Providers Assume Expanded Responsibilities
By Rita Peters
Contract service providers are playing a more diverse role in drug development.
More ...

Study: CMO Technical Expertise is Not Enough
By Eric Langer
Sponsors are demanding high levels of professionalism, performance, and effectiveness in managerial areas to accompany CMOs’ technical expertise.
More ...



Business
African Biopharma Market Presents Long-term Opportunities
By Cynthia A. Challener, PhD
Biopharma companies seeking to leverage opportunities in African market must adopt the right strategy to achieve success.
More ...

FDA Strategies Designed to Speed Generic Drug Approvals
By Jill Wechsler
A surge in generic drug applications is testing FDA’s ability to reduce the backlog of ANDAs.
More ...



Advertisement:

Business development’s best friend
Rely on the PharmSource Lead Sheet for real-time clinical drug pipeline updates, company contacts and market intelligence – the top CROs, CMOs and CDMOs do. Having the right information at the right time is the key to success. Don’t be the last to know. Visit us today to request a test-drive of the PharmSource Lead Sheet.


Supply Chain
Preparing to Meet Counterfeiting Regulations
By Jennifer Markarian
An expert discusses how companies should be preparing to meet the requirements of the Drug Supply Chain Security Act, which requires phase-in of requirements to prevent counterfeiting.
More ...


Advertisement:

Analytical Challenges and Case Studies in Method Development for Fixed-Dose Combinations
On Demand Webcast
Register Free at: www.pharmtech.com/method_development


API Synthesis and Manufacturing
Supply Chain Security Tops Concerns for Biopharma Raw Materials
By Cynthia A. Challener, PhD
Biopharma are looking to reduce risk, increase performance, and optimize productivity in raw material development.
More ...


Advertisement:

API Characterization for a Speedy and Successful Formulation Strategy
September 18, 2014 at 11:00 AM EDT
Register Free at: www.pharmtech.com/strategy


 

Advertising Contact:
Mike Tracey

Contact the Editors:
ptpress@advanstar.com